Summary
This prediction ended on 17.02.15 with a price of €125.48. The prediction closed with a disappointing performance of 29.36%. Jutsch has 50% into this predictionBayer is a multinational pharmaceutical and life sciences company headquartered in Germany. The company was founded in 1863 and has since grown to become a global leader in the fields of pharmaceuticals, agriculture, and consumer health. Bayer is listed on the Frankfurt Stock Exchange and also trades over-the-counter in the United States under the ticker symbol BAYZF. The company's products include prescription drugs, over-the-counter medicines, and agrochemicals, and it operates in more than 90 countries around the world.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Bayer AG | -3.105% | -3.105% | -48.042% | -49.204% |
| iShares Core DAX® | -0.268% | 5.471% | 14.271% | 19.027% |
| iShares Nasdaq 100 | 1.854% | 7.851% | 35.426% | 58.415% |
| iShares Nikkei 225® | 0.284% | 1.729% | 9.943% | 7.045% |
| iShares S&P 500 | 1.178% | 5.269% | 27.989% | 49.400% |
Comments by Jutsch for this prediction
In the thread Bayer AG diskutieren
Gewinn mitzunehmen ist richtig.
Die wichtigsten Konjunkturindikatoren in Euroraum und USA sind im Sinkflug. Ifo- Index und ZEW Index sind gefallen, sowie auch viel beachtete Einkaufsmanagerindex in der USA. Man braucht kein Prophet zu sein. Das sind Vorboten der konjunkturellen Abschwächung. Kein gutes Umfeld für die zyklischen Aktien. Die Aktie wird schwer haben. Die konjunkturelle Abschwächung wird sich auf den Gewinn des Unternehmens bemerkbar machen. Klarer Verkauf.